Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Pharmacokinetics and Pharmacodynamics of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria

NCT04079257 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT04079257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04079257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Pharmacokinetics and Pharmacodynamics of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria
Lead sponsor
Radboud University Medical Center
Phase
Observational
Overall status
Completed
Start date
February 23, 2021
Completion date
July 1, 2022
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

eculizumab, paroxysmal nocturnal hemoglobinuria, pk-pd